Drug Information

Drug General Information
Drug ID
D0T4ZM
Former ID
DNC001469
Drug Name
Triglycyl-lysine-vasopressin
Drug Type
Small molecular drug
Indication Discovery agent Investigative [537975]
Structure
Download
2D MOL

3D MOL
Formula
C11H8O2
Canonical SMILES
CC1=CC(=O)C2=CC=CC=C2C1=O
InChI
1S/C11H8O2/c1-7-6-10(12)8-4-2-3-5-9(8)11(7)13/h2-6H,1H3
InChIKey
MJVAVZPDRWSRRC-UHFFFAOYSA-N
CAS Number
CAS 12001-79-5
PubChem Compound ID
4055
PubChem Substance ID
7751, 70547, 607330, 853737, 853809, 3133921, 6380040, 7849394, 7891061, 8136904, 8149919, 8152543, 10321386, 10528213, 11112142, 11120351, 11120839, 11121327, 11335255, 11341462, 11360494, 11361645, 11364122, 11364936, 11366684, 11367498, 11369246, 11370060, 11373099, 11374123, 11375660, 11377408, 11378230, 11408337, 11446754, 11461466, 11466487, 11467607, 11485003, 11486213, 11487047, 11489010, 11492537, 11495042, 11532917, 11533196, 12016111, 14772598, 22389508, 24871411
ChEBI ID
ChEBI:28384
SuperDrug ATC ID
B02BA02
SuperDrug CAS ID
cas=000058275
Target and Pathway
Target(s) Vasopressin V1 receptor Target Info Agonist [537975]
References
Ref 537975Evidence in hyponatremia related to inappropriate secretion of ADH that V1 receptor stimulation contributes to the increase in renal uric acid clearance. J Am Soc Nephrol. 1996 May;7(5):805-10.
Ref 537975Evidence in hyponatremia related to inappropriate secretion of ADH that V1 receptor stimulation contributes to the increase in renal uric acid clearance. J Am Soc Nephrol. 1996 May;7(5):805-10.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.